A new mRNA therapy tested in mice may target the root cause of the potentially fatal pregnancy disorder preeclampsia.

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups ...

The protein-based vaccine now covers the LP.8.1 variant and can be given to adolescents aged 12 years or older who previously received mRNA vaccines.

France enacted a controversial new law in February that critics say could be used against anyone oppos ing injections with mRNA vaccines or other treatments recommended by the state and based upon ...

When it comes to mRNA injections for COVID, Americans are 100% dependent on the FDA and vaccine manufacturers to assess and confirm purity and consistency. That might be okay if the testing ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust into the limelight during the COVID-19 pandemic, but had been in ...

An mRNA therapy could treat the potentially deadly pregnancy disorder preeclampsia, which currently has no cure, a new study in rodents finds. There are currently no drugs that slow the progression of ...